Biotech · Private company
Price Vision Group
Track this companyFree. Adds Price Vision Group to your Dealase workspace and tells you when its record changes.
Clinical trials82 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- 10 minute photoactivation of riboflavin 0.1%Phase 3 · Corneal NeovascularizationClinicalTrials.gov · fetched Nov 12, 2026
- 30 minute photoactivation of riboflavin 0.1%Phase 3 · Corneal NeovascularizationClinicalTrials.gov · fetched Nov 12, 2026
- NetarsudilPhase 3 · Fuchs' Endothelial DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Netarsudil Ophthalmic SolutionPhase 3 · Fuchs Endothelial DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- riboflavin 0.1%Phase 3 · KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- Riboflavin 0.1% ophthalmic solution and non-pulsed lightPhase 3 · KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- Riboflavin 0.1% ophthalmic solution and pulsed lightPhase 3 · KeratoconusClinicalTrials.gov · fetched Nov 12, 2026
- Aqueous shuntPrimary Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- loteprednol etabonate 0.25% ophthalmic suspensionCorneal Endothelial DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- TrueTearCataractClinicalTrials.gov · fetched Nov 12, 2026
- XenPrimary Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal EctasiaPHASE2_PHASE3 · RECRUITING · started Oct 1, 2025ClinicalTrials.gov NCT07841470 · fetched Nov 12, 2026
- Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant RejectionPHASE4 · COMPLETED · started Nov 23, 2021ClinicalTrials.gov NCT05136443 · fetched Nov 12, 2026
- Corneal Crosslinking for Treatment of Corneal NeovascularizationPHASE2_PHASE3 · RECRUITING · started May 3, 2021ClinicalTrials.gov NCT04787471 · fetched Nov 12, 2026
- Effect of Xen Implantation on the Aqueous Humor ProteomeTERMINATED · started Oct 24, 2019ClinicalTrials.gov NCT04141865 · fetched Nov 12, 2026
- Rhopressa for Corneal Edema Associated With Fuchs DystrophyPHASE2_PHASE3 · COMPLETED · started Aug 5, 2019ClinicalTrials.gov NCT04051463 · fetched Nov 12, 2026
- Trial of Netarsudil for Acceleration of Corneal Endothelial RestorationPHASE2_PHASE3 · TERMINATED · started Jul 22, 2019ClinicalTrials.gov NCT03971357 · fetched Nov 12, 2026
- Comparison of Standard vs. Accelerated Corneal CrosslinkingPHASE2_PHASE3 · COMPLETED · started Apr 16, 2019ClinicalTrials.gov NCT03922542 · fetched Nov 12, 2026
- Effect of TrueTear Corneal Surface ImagingNA · COMPLETED · started Aug 13, 2018ClinicalTrials.gov NCT03637348 · fetched Nov 12, 2026